These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 12971396)
21. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
29. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States. Miller CP; Ullrich JW Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591 [TBL] [Abstract][Full Text] [Related]
31. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]
32. Patent threat in emerging economies shifts to biotech. Jayaranam K Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760 [No Abstract] [Full Text] [Related]
34. [The status of a nonpatented drug of which the basic molecule in patented]. Petranker L; Stenger J Ann Pharm Fr; 1975 Nov; 33(11):619-25. PubMed ID: 1231608 [No Abstract] [Full Text] [Related]
35. Biotech patents-business as usual? Lawrence S Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861 [No Abstract] [Full Text] [Related]
36. Effect of drug patent abolition on a Canadian pharmaceutical company. LOZINSKI E Appl Ther; 1963 May; 5():441-2. PubMed ID: 13931335 [No Abstract] [Full Text] [Related]
37. Drug research. WHO panel weighs radical ideas. Enserink M Science; 2006 Dec; 314(5804):1373. PubMed ID: 17138875 [No Abstract] [Full Text] [Related]
38. Are drug proprietary names necessary? D'Arcy PF; Hadden DR Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):117-21. PubMed ID: 10967746 [No Abstract] [Full Text] [Related]
39. Effect of drug patent abolition on an international pharmaceutical company. DAILY RF Appl Ther; 1963 May; 5():445-7. PubMed ID: 14024668 [No Abstract] [Full Text] [Related]
40. More lawyers. More bureaucrats. Less information on drug safety. Walker AM Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):394-5. PubMed ID: 16739244 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]